SuperworthMiniMed MMED
- Market cap
- $5.2B
- PE
- n/m
- one or more of the four quarters through 2026-07-31 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- one or more of the four quarters through 2026-07-31 missing
- EV/EBIT
- n/m
- not a meaningful number
- Revenue, 12 months
- n/m
- one or more of the four quarters through 2026-07-31 missing
- Net margin
- n/m
- one or more of the four quarters through 2026-07-31 missing
- Free cash flow yield
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|
| $687M | $724M | $723M | $790M | $837M | $843M | |
| Cost of revenue | $292M | $318M | $314M | $428M | $357M | $378M |
| Gross profit | $395M | $405M | $409M | $362M | $480M | $465M |
| R&D | $112M | $107M | $125M | $114M | $99M | $115M |
| SG&A | $268M | $276M | $283M | $309M | $299M | $312M |
| $21M | −$148M | −$13M | −$100M | −$93M | $5M | |
| Pre-tax income | $21M | −$148M | −$13M | −$99M | −$92M | $4M |
| $28M | $21M | $3M | $12M | $93M | $4M | |
| Net income | −$10M | −$172M | −$19M | −$119M | −$185M | $0 |
| −$0.04 | −$0.68 | −$0.08 | −$0.47 | −$0.69 | $0.00 | |
| 252.8M | 252.8M | 252.8M | 252.8M | 268M | 281M |
EPS, diluted: Q4 FY25 and Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY25 and Q4 FY26: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Instruments & Supplies nearest MiniMed's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MMEDMiniMed | $5.2B | n/m | n/a | n/m | n/m | n/m | |
| HAEHaemonetics | $5.4B | 58.1× | 51.6× | 4.0× | +0% | 7.1% | |
| MMSIMerit Medical Systems | $5.6B | 38.6× | 57.5× | 3.5× | +10% | 9.2% | |
| VNTVontier | $4.6B | 14.3× | 13.5× | 1.5× | +1% | 11.3% | |
| BMIBadger Meter | $4.4B | 35.3× | 47.6× | 5.0× | −2% | 14.3% | |
| ICUIICU Medical | $4.2B | 141× | 57.8× | 1.9× | −9% | 1.4% | |
| NVSTEnvista | $3.8B | 40.7× | 27.9× | 1.3× | +12% | 3.3% | |
| MSAMSA Safety | $7B | 22.7× | 36.3× | 3.6× | +6% | 16.1% | |
| WRBYWarby Parker | $3.2B | 370× | 366× | 3.5× | +11% | 0.8% | |
| ATRCAtriCure | $3B | 281× | 58.4× | 5.3× | +14% | 1.9% | |
| PODDInsulet | $10.3B | 27.9× | 63.0× | 3.4× | +29% | 12.3% | |
| Peer median | $4.5B | 39.6× | 54.5× | 3.5× | +8% | 8.2% |
More on MiniMed
Each number over time
Its groups
About
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .